PYRIDOXINE HYDROCHLORIDE VITAMIN B6 MARKET ANALYSIS

Market News

Key Developments

• Key players are adopting in-organic growth strategies such as new product launches, business expansion in order to strengthen its position in the Global pyridoxine hydrochloride (Vitamin B6) market. For instance, in April 2018, Duchesnay a pharmaceutical company specializing in women's health launched Bonjesta (doxylamine succinate and pyridoxine hydrochloride), multilayer extended-release tablets in the U.S. market. Bonjesta is indicated for the treatment of nausea and vomiting of pregnancy ("NVP") in women who do not respond to conservative management.
• In June 2019, Teva introduced doxylamine succinate and pyridoxine hydrochloride delayed-release tablets in a dosage strength of 10/mg/10 mg in the market. The new tablets are used to treat nausea and vomiting of pregnancy in women who have not improved with change in diet or other non-medicine treatments.